Iluvit & NDASH- An investigator initiated monocentric pilot study to investigate inflammation parameters and growth factors in the vitreous during a cortisone long-term therapy with Iluvien in patients with chronic diabetic macular edema
Phase of Trial: Phase IV
Latest Information Update: 06 Dec 2019
Price : $35 *
At a glance
- Drugs Fluocinolone acetonide (Primary)
- Indications Diabetic macular oedema
- Focus Biomarker; Pharmacodynamics
- Acronyms Iluvit
- 05 Dec 2019 Status changed from active, no longer recruiting to completed.
- 21 May 2019 Status changed from recruiting to active, no longer recruiting.
- 05 Jan 2018 New trial record